SCD and cancer: The treatment of cancer cells with the SCD1 inhibitor, CVT-11127, caused adenosine monophosphate-activated protein kinase (AMPK) activation via phosphorylation at Thr172, which in turn led to inactivation of the phosphorylation of ACC at Ser79 [78,91].